UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A single index chart move often signals momentum shifts; understanding its implications helps traders frame positions and adapt risk controls.
26,274 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Bittensor's TAO aims to blend AI training services with blockchain incentives. After a sharp rally, investors wonder ...
Investors are weighing the latest earnings from D-Wave Quantum. While losses persisted, revenue beat expectations in ...
NVIDIA stock struggled over the last week despite solid earnings. This guide breaks down the reasons behind the move ...
June markets test XLE as oil dynamics and earnings timing hedges collide. A handful of energy giants drive the ETF, u...
After 15 years of bullish calls on banks, a veteran analyst pivots to private equity and other alternatives, downgrad...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
A major institutional move is shaping Balchem's next chapter. As the company posts record sales, a new investor stake...
Strategy, the world’s largest Bitcoin holder, quietly added to its treasury last week, acquiring just over 1,000 BTC ...
Astronics reports a mixed Q1 2026 that tests the durability of its backlog and margin recovery. This article breaks d...
Amazon is edging toward a $3 trillion market cap as cloud growth and aggressive capital spending power a potential mi...
Berkshire Hathaway disclosed a $2.65 billion stake in Delta Air Lines, marking a sharp shift from Buffett-era airline...